ArticleMolecular medicine reports2025

Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer.

Jinfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.